Contrary to other tumors, they used in vivo and in vitro experiments to demonstrate that TPX2 played an inhibitory role in HCC, which was accomplished by regulating the NF-κB signaling pathway and the expression of CXCR5 of infiltrating CD8 + T cells in HCC. Here, TPX2 is linked to hepatocellular carcinoma.